Log in

Repair effect of diabetic ulcers with recombinant human epidermal growth factor loaded by sustained-release microspheres

  • Article
  • Published:
Science in China Series C: Life Sciences Aims and scope Submit manuscript

Abstract

In this study the w/o/w extraction-evaporation technique was adopted to prepare poly(lactic-co-glycolic acid) (PLGA) microspheres loading recombinant human epidermal growth factor (rhEGF). The microspheres were characterized for morphology by transmission electron microscopy (TEM) and particle size distribution. The release performances, the proliferation effects and therapeutic effects of rhEGF-loaded PLGA microspheres were all studied. The results showed that these spherical microspheres had a narrow size distribution and a high drug encapsulation efficiency (85.6%). RhEGF-loaded microspheres enhanced the growth rate of fibroblasts and wound healing more efficiently than pure rhEGF. The number of the proliferating cell nuclear antigen (PCNA) in the epidermis layer with the microsphere treatment was significantly larger than those of the control groups. Overall locally sustained delivery of rhEGF from biodegradable PLGA microspheres may serve as a novel therapeutic strategy for diabetic ulcer repair.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rathur H M, Boultun A J M. The diabetic foot. Clin Dermatol, 2007, 25: 109–120, 17276208, 10.1016/j.clindermatol.2006.09.015

    Article  PubMed  Google Scholar 

  2. Clarke-Moloney M, Lyons G M, Burke P E, et al. A review of technological approaches to venous ulceration. Critical Rev Biomed Eng, 2005, 33(6): 511–556, 1:STN:280:DC%2BD28%2FgsVyjuw%3D%3D

    Article  CAS  Google Scholar 

  3. Okumura K, Kiyohara Y, Komada F, et al. Improvement in wound healing by epidermal growth factor (EGF) ointment. I. Effect of nafamostat, gabexate, or gelatin on stabilization and efficacy of EGF. Pharm Res, 1990, 7(12): 1289–1293, 2128896, 10.1023/A:1015946123697, 1:CAS:528:DyaK3MXjs1KhsQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  4. Couvreur P, Blanco-Prieto M J, Puisieux F, et al. Multiple emulsion technology for the design of microspheres containing peptides and oligopeptides. Adv Drug Deliver Rev, 1997, 28(1): 85–96, 10.1016/S0169-409X(97)00052-5, 1:CAS:528:DyaK2sXntVOjsrk%3D

    Article  CAS  Google Scholar 

  5. Jorgensen L, Moeller E H, van de Weert M, et al. Preparing and evaluating delivery systems for proteins. Eur J Pharm Sci, 2006, 29: 174–182, 16828267, 10.1016/j.ejps.2006.05.008, 1:CAS:528:DC%2BD28XhtFentr%2FL

    Article  PubMed  CAS  Google Scholar 

  6. Freiberg S, Zhu X X. Polymer microspheres for controlled drug release. Int J Pharm, 2004, 282: 1–18, 15336378, 10.1016/j.ijpharm.2004.04.013, 1:CAS:528:DC%2BD2cXntVGhs7o%3D

    Article  PubMed  CAS  Google Scholar 

  7. Kishan V, Oliver D W, Dillis V V, et al. Growth factor modulation of fibroblast proliferation, differentiation, and invasion: Implications for tissue valve engineering. Tissue Eng, 2006, 12(10): 2707–2716, 10.1089/ten.2006.12.2707

    Article  Google Scholar 

  8. Kwon Y B, Kim H W, Roh D H, et al. Topical application of epidermal growth factor accelerates wound healing by myofibroblast proliferation and collagen synthesis in rat. J Vet Sci, 2006, 7(2): 105–109, 16645332

    Article  PubMed Central  PubMed  Google Scholar 

  9. Reis C P, Neufeld R J, Ribeiro A J, et al. Nanoencapsulation. II. Biomedical applications and current status of peptide and protein nanoparticulate delivery systems. Nat Med, 2006, 2(2): 53–65, 1:CAS:528:DC%2BD28XntVCgtbc%3D

    CAS  Google Scholar 

  10. Kim T H, Lee H, Park T G. Pegylated recombinant human epidermal growth factor (rhEGF) for sustained release from biodegradable PLGA microspheres. Biomaterials, 2002, 23: 2311–2317, 12013178, 10.1016/S0142-9612(01)00365-9, 1:CAS:528:DC%2BD38**tlaktb8%3D

    Article  PubMed  CAS  Google Scholar 

  11. Cleland J L, Duenas E T, Park A, et al. Development of poly-(D,L-lactide-coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis. J Control Release, 2001, 72: 13–24, 11389981, 10.1016/S0168-3659(01)00258-9, 1:CAS:528:DC%2BD3MXktVGlu7Y%3D

    Article  PubMed  CAS  Google Scholar 

  12. Loo J S C, Ooi C P, Boey F Y C. Degradation of poly(lactide-co-glycolide) (PLGA) and poly(L-lactide) (PLLA) by electron beam radiation. Biomaterials, 2005, 26(12): 1359–1367, 15482823, 10.1016/j.biomaterials.2004.05.001, 1:CAS:528:DC%2BD2cXosFSltbw%3D

    Article  PubMed  CAS  Google Scholar 

  13. Anderson J M, Shive S M. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Delivery Rev, 1997, 28(1): 5–24, 10.1016/S0169-409X(97)00048-3, 1:CAS:528:DyaK2sXntVKqu70%3D

    Article  CAS  Google Scholar 

  14. Liu X Y, Chang J, Guo Y S, et al. Preparation of the Immunonanoparticles Targeting to Lens Epithelial Cells. Chin J Biomed Eng, 2004, 23(6): 583–588, 1:CAS:528:DC%2BD2MXnsF2rsLw%3D

    CAS  Google Scholar 

  15. Sun T Z, Wang Y P, Yang Y H, et al. Comparison of the effects of rhEGF with rhbFGF on the acceleration of wound healing. Chin J Reparat Reconstruct Surg, 1999, 13(5): 278–282, 1:CAS:528:DC%2BD3cXkvF2itA%3D%3D

    CAS  Google Scholar 

  16. Prelich G, Tan C K, Kostura M, et al. Functional identity proliferating cell nuclear antigen and a DNA polymerase delta auxiliary protein. Nature, 1987, 326: 517–520, 2882424, 10.1038/326517a0, 1:CAS:528:DyaL2sXhvFWntrw%3D

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to ** Chang.

Additional information

Supported by the National Natural Science Foundation of China (Grant No. 50373033), the Applied Foundational Research Key Fund of Tian** (Grant No. 05YFJZJC01001) and the International Cooperative Fund of Tian** (Grant No. 05YFGHHZ20070)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dong, X., Xu, J., Wang, W. et al. Repair effect of diabetic ulcers with recombinant human epidermal growth factor loaded by sustained-release microspheres. SCI CHINA SER C 51, 1039–1044 (2008). https://doi.org/10.1007/s11427-008-0126-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11427-008-0126-5

Keywords

Navigation